Eli Lilly & Co. (LLY)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 6 |
Ownership rank: | 70 |
% of all portfolios: | 0.075% |
Hold Price * : | $626.72 |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
0 |
$0 |
Sells |
83 |
$608,633,217 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
≡ |
Chase Coleman - Tiger Global Management |
3.69 |
Reduce 3.17% |
890,000 |
518,799,000 |
≡ |
Mairs & Power Growth Fund |
1.78 |
|
124,539 |
96,886,000 |
≡ |
Viking Global Investors |
0.30 |
Buy |
138,728 |
80,867,000 |
≡ |
Polen Capital Management |
0.20 |
Reduce 4.65% |
594,801 |
81,021,000 |
≡ |
David Katz - Matrix Asset Advisors |
0.03 |
Buy |
297 |
231,000 |
≡ |
Lee Ainslie - Maverick Capital |
0.02 |
Add 22.15% |
2,002 |
1,167,000 |
Open Market Insider Buys
Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
16 Aug 2022 |
TAI JACKSON P |
Director |
12 Aug 2022 |
656 |
304.19 |
199,549 |
07 Mar 2022 |
RUNGE MARSCHALL S |
Director |
01 Mar 2022 |
202 |
246.78 |
49,850 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock